{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:53:21Z","timestamp":1774313601667,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13304-025-02211-3","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T14:07:39Z","timestamp":1746626859000},"page":"1581-1591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of predictive factors for lymph node metastasis in thyroid microcarcinoma: a two-year experience from two high-volume centers"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-0111","authenticated-orcid":false,"given":"Giovanni","family":"Tacchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pedicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfilippo","family":"Crucitti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"issue":"3","key":"2211_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","volume":"42","author":"Y Ito","year":"2018","unstructured":"Ito Y et al (2018) Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients. World J Surg 42(3):615\u2013622","journal-title":"World J Surg"},{"key":"2211_CR2","unstructured":"AIOM, I Numeri del cancro. 2023."},{"key":"2211_CR3","unstructured":"AIOM. I Numeri del cancro. 2019."},{"issue":"10061","key":"2211_CR4","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet 388(10061):2783\u20132795","journal-title":"Lancet"},{"issue":"6","key":"2211_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/cen.14529","volume":"95","author":"R Sutherland","year":"2021","unstructured":"Sutherland R et al (2021) Papillary thyroid microcarcinoma: Is active surveillance always enough? Clin Endocrinol (Oxf) 95(6):811\u2013817","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"13","key":"2211_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H et al (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA 317(13):1338\u20131348","journal-title":"JAMA"},{"key":"2211_CR7","volume-title":"SEER Cancer Statistics Review, 1975\u20132016","author":"N Howlader","year":"2019","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2019) SEER Cancer Statistics Review, 1975\u20132016. National Cancer Institute, Bethesda"},{"issue":"7","key":"2211_CR8","doi-asserted-by":"publisher","first-page":"e2639","DOI":"10.1210\/clinem\/dgaa223","volume":"105","author":"R Vigneri","year":"2020","unstructured":"Vigneri R, Malandrino P, Russo M (2020) Is thyroid cancer increasing in incidence and aggressiveness? J Clin Endocrinol Metab 105(7):e2639","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2211_CR9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMp1604412","volume":"375","author":"S Vaccarella","year":"2016","unstructured":"Vaccarella S et al (2016) Worldwide thyroid-cancer epidemic? the increasing impact of overdiagnosis. N Engl J Med 375(7):614\u2013617","journal-title":"N Engl J Med"},{"issue":"6","key":"2211_CR10","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clon.2010.03.013","volume":"22","author":"RC Smallridge","year":"2010","unstructured":"Smallridge RC, Copland JA (2010) Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) 22(6):486\u2013497","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2211_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejca.2017.02.023","volume":"77","author":"L Dal Maso","year":"2017","unstructured":"Dal Maso L et al (2017) Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 77:140\u2013152","journal-title":"Eur J Cancer"},{"issue":"10387","key":"2211_CR12","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW et al (2023) Thyroid cancer. Lancet 401(10387):1531\u20131544","journal-title":"Lancet"},{"key":"2211_CR13","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0067","author":"C Durante","year":"2023","unstructured":"Durante C et al (2023) European thyroid association clinical practice guidelines for thyroid nodule management. Eur Thyroid J. https:\/\/doi.org\/10.1530\/ETJ-23-0067","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2211_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/jcm12020398","volume":"12","author":"S Amendola","year":"2023","unstructured":"Amendola S et al (2023) Evaluation of the performance of ACR TI-RADS also considering those nodules with no indication of FNAC: a single-center experience. J Clin Med 12(2):398","journal-title":"J Clin Med"},{"issue":"2","key":"2211_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12020-023-03486-5","volume":"83","author":"J Ruan","year":"2024","unstructured":"Ruan J et al (2024) Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients. Endocrine 83(2):414\u2013421","journal-title":"Endocrine"},{"issue":"9","key":"2211_CR16","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1245\/s10434-008-0044-6","volume":"15","author":"JL Roh","year":"2008","unstructured":"Roh JL, Kim JM, Park CI (2008) Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15(9):2482\u20132486","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2211_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","volume":"34","author":"Y Ito","year":"2010","unstructured":"Ito Y et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34(1):28\u201335","journal-title":"World J Surg"},{"issue":"6","key":"2211_CR18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s13304-023-01522-7","volume":"75","author":"P Del Rio","year":"2023","unstructured":"Del Rio P et al (2023) Management of surgical diseases of thyroid gland indications of the United Italian Society of Endocrine Surgery (SIUEC). Updates Surg 75(6):1393\u20131417","journal-title":"Updates Surg"},{"issue":"1","key":"2211_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/RLU.0b013e318279bc65","volume":"38","author":"G Ardito","year":"2013","unstructured":"Ardito G et al (2013) Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy. Clin Nucl Med 38(1):25\u201328","journal-title":"Clin Nucl Med"},{"issue":"4","key":"2211_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/SLA.0b013e318230036d","volume":"254","author":"XM Yu","year":"2011","unstructured":"Yu XM et al (2011) Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254(4):653\u2013660","journal-title":"Ann Surg"},{"issue":"1","key":"2211_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/s12885-019-5835-6","volume":"19","author":"C Liu","year":"2019","unstructured":"Liu C et al (2019) Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer 19(1):622","journal-title":"BMC Cancer"},{"issue":"6","key":"2211_CR22","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1002\/cam4.5507","volume":"12","author":"X Wu","year":"2023","unstructured":"Wu X et al (2023) Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma. Cancer Med 12(6):7560\u20137566","journal-title":"Cancer Med"},{"issue":"3","key":"2211_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40618-021-01675-5","volume":"45","author":"X Wei","year":"2022","unstructured":"Wei X et al (2022) Development and validation of an individualized nomogram for predicting the high-volume (> 5) central lymph node metastasis in papillary thyroid microcarcinoma. J Endocrinol Invest 45(3):507\u2013515","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"2211_CR24","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1089\/thy.2015.0130","volume":"25","author":"A Al Afif","year":"2015","unstructured":"Al Afif A et al (2015) Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25(9):1008\u20131012","journal-title":"Thyroid"},{"issue":"3","key":"2211_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13304-023-01479-7","volume":"75","author":"K Ozdemir","year":"2023","unstructured":"Ozdemir K et al (2023) Should multifocality be an indication for prophylactic central neck dissection in papillary thyroid cancer? Updates Surg 75(3):701\u2013706","journal-title":"Updates Surg"},{"key":"2211_CR26","doi-asserted-by":"publisher","first-page":"760901","DOI":"10.3389\/fendo.2021.760901","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng X et al (2021) High incidence of distant metastasis is associated with histopathological subtype of pediatric papillary thyroid cancer\u2014a retrospective analysis based on SEER. Front Endocrinol (Lausanne) 12:760901","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2211_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s13304-024-01779-6","volume":"76","author":"S Amendola","year":"2024","unstructured":"Amendola S et al (2024) Papillary thyroid carcinoma: <\/= 10 mm does not always mean pN0 A multicentric real-world study. Updates Surg 76(3):1055\u20131061","journal-title":"Updates Surg"},{"issue":"6","key":"2211_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40618-014-0062-0","volume":"37","author":"F Nardi","year":"2014","unstructured":"Nardi F et al (2014) Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 37(6):593\u2013599","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2211_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000354537","volume":"2","author":"L Leenhardt","year":"2013","unstructured":"Leenhardt L et al (2013) 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2(3):147\u2013159","journal-title":"Eur Thyroid J"},{"issue":"1","key":"2211_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-022-03146-0","volume":"78","author":"C Pizzimenti","year":"2022","unstructured":"Pizzimenti C et al (2022) Aggressive variants of follicular cell-derived thyroid carcinoma: an overview. Endocrine 78(1):1\u201312","journal-title":"Endocrine"},{"issue":"1","key":"2211_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/thy.2014.0294","volume":"25","author":"SC Londero","year":"2015","unstructured":"Londero SC et al (2015) Papillary thyroid carcinoma in Denmark, 1996\u20132008: outcome and evaluation of established prognostic scoring systems in a prospective national cohort. Thyroid 25(1):78\u201384","journal-title":"Thyroid"},{"issue":"3","key":"2211_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.20892\/j.issn.2095-3941.2017.0051","volume":"14","author":"M Gao","year":"2017","unstructured":"Gao M et al (2017) 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma. Cancer Biol Med 14(3):203\u2013211","journal-title":"Cancer Biol Med"},{"issue":"1","key":"2211_CR33","doi-asserted-by":"publisher","first-page":"101630","DOI":"10.1016\/j.beem.2022.101630","volume":"37","author":"I Sugitani","year":"2023","unstructured":"Sugitani I (2023) Active surveillance of low-risk papillary thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab 37(1):101630","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2211_CR34","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1210\/clinem\/dgac739","volume":"108","author":"JS Lee","year":"2023","unstructured":"Lee JS et al (2023) Aggressive subtypes of papillary thyroid carcinoma smaller than 1 cm. J Clin Endocrinol Metab 108(6):1370\u20131375","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2211_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Ito Y et al (2014) Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 24(1):27\u201334","journal-title":"Thyroid"},{"issue":"12","key":"2211_CR36","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1210\/jc.2012-1257","volume":"97","author":"A Machens","year":"2012","unstructured":"Machens A, Dralle H (2012) Correlation between the number of lymph node metastasis and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97(12):4375\u20134382","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2211_CR37","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/SLA.0b013e3181a40919","volume":"249","author":"BS Koo","year":"2009","unstructured":"Koo BS et al (2009) Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 249(5):840\u2013844","journal-title":"Ann Surg"},{"issue":"5","key":"2211_CR38","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/17446651.2022.2112176","volume":"17","author":"F Frasca","year":"2022","unstructured":"Frasca F et al (2022) Early detection of suspicious lymph nodes in differentiated thyroid cancer. Expert Rev Endocrinol Metab 17(5):447\u2013454","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"2211_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s13304-022-01440-0","volume":"75","author":"R Shahriarirad","year":"2023","unstructured":"Shahriarirad R et al (2023) Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study. Updates Surg 75(3):679\u2013689","journal-title":"Updates Surg"},{"key":"2211_CR40","doi-asserted-by":"publisher","first-page":"8270622","DOI":"10.1155\/2021\/8270622","volume":"2021","author":"P Yang","year":"2021","unstructured":"Yang P et al (2021) Effect of prophylactic central lymph node dissection on locoregional recurrence in patients with papillary thyroid microcarcinoma. Int J Endocrinol 2021:8270622","journal-title":"Int J Endocrinol"},{"issue":"7","key":"2211_CR41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","volume":"41","author":"F Pacini","year":"2018","unstructured":"Pacini F et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 41(7):849\u2013876","journal-title":"J Endocrinol Invest"},{"key":"2211_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1477-7819-10-67","volume":"10","author":"YL Zhou","year":"2012","unstructured":"Zhou YL et al (2012) Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis: a retrospective study. World J Surg Oncol 10:67","journal-title":"World J Surg Oncol"},{"issue":"1","key":"2211_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0194599820966995","volume":"165","author":"N Shukla","year":"2021","unstructured":"Shukla N, Osazuwa-Peters N, Megwalu UC (2021) Association between age and nodal metastasis in papillary thyroid carcinoma. Otolaryngol Head Neck Surg 165(1):43\u201349","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"2211_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/cen.14834","volume":"98","author":"Z Wang","year":"2023","unstructured":"Wang Z et al (2023) Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a retrospective study and meta-analysis. Clin Endocrinol (Oxf) 98(4):609\u2013621","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2211_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncr.25369","volume":"117","author":"MR Vriens","year":"2011","unstructured":"Vriens MR et al (2011) Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer 117(2):259\u2013267","journal-title":"Cancer"},{"issue":"2","key":"2211_CR46","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jss.2009.05.031","volume":"160","author":"W Moses","year":"2010","unstructured":"Moses W et al (2010) Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res 160(2):179\u2013183","journal-title":"J Surg Res"},{"issue":"35","key":"2211_CR47","doi-asserted-by":"publisher","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","volume":"9","author":"P Yu","year":"2023","unstructured":"Yu P et al (2023) TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. Sci Adv 9(35):eadg7125","journal-title":"Sci Adv"},{"issue":"4","key":"2211_CR48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/thy.2016.0628","volume":"27","author":"BR Haugen","year":"2017","unstructured":"Haugen BR et al (2017) American thyroid association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid 27(4):481\u2013483","journal-title":"Thyroid"},{"issue":"6","key":"2211_CR49","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1530\/EC-21-0164","volume":"10","author":"W Wang","year":"2021","unstructured":"Wang W et al (2021) Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis. Endocr Connect 10(6):656\u2013666","journal-title":"Endocr Connect"},{"issue":"1","key":"2211_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/cancers12010246","volume":"12","author":"G Tallini","year":"2020","unstructured":"Tallini G et al (2020) Does the Site of origin of the microcarcinoma with respect to the thyroid surface matter? A multicenter pathologic and clinical study for risk stratification. Cancers (Basel) 12(1):246","journal-title":"Cancers (Basel)"},{"key":"2211_CR51","doi-asserted-by":"publisher","first-page":"887977","DOI":"10.3389\/fonc.2022.887977","volume":"12","author":"Z Cao","year":"2022","unstructured":"Cao Z et al (2022) Comprehensive analysis of tissue proteomics in patients with papillary thyroid microcarcinoma uncovers the underlying mechanism of lymph node metastasis and its significant sex disparities. Front Oncol 12:887977","journal-title":"Front Oncol"},{"issue":"5","key":"2211_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4158\/EP.13.5.498","volume":"13","author":"EL Mazzaferri","year":"2007","unstructured":"Mazzaferri EL (2007) Management of low-risk differentiated thyroid cancer. Endocr Pract 13(5):498\u2013512","journal-title":"Endocr Pract"},{"issue":"34","key":"2211_CR53","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3346\/jkms.2023.38.e264","volume":"38","author":"HS Baek","year":"2023","unstructured":"Baek HS et al (2023) Cost-effectiveness of active surveillance compared to early surgery of small papillary thyroid cancer: a retrospective study on a Korean population. J Korean Med Sci 38(34):e264","journal-title":"J Korean Med Sci"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02211-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:50:33Z","timestamp":1757487033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02211-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02211-3","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and with the approval of the Internal Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Every patient have signed an informed consent as we have reported in the methods sections.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}